Mgr. Jarmila Herůdková, Ph.D.

odborná pracovnice – Výzkumná skupina Petra Vaňhary: Tissue plasticity and regeneration

korespondenční adresa:
Kamenice 753/5, 625 00 Brno

kancelář: bud. F01B1/225
Kamenice 126/3
625 00 Brno

telefon:	549 49 5589
e‑mail:

Základní údaje

Životopis

Školitel

Kvalifikace

Publikace

Druh

Počet publikací: 27

2013

Combined treatment of PPARgamma ligand with oxaliplatin affect the cell cycle and death in colon cell line both sensitive and resistant to oxaliplatin

STRAKOVÁ Nicol HOFMANOVÁ Jiřina ZAPLETAL Ondřej SOUČEK Karel FEDR Radek BOUCHAL Jan EHRMANN Jiří KOLÁŘ Zdeněk HYRŠLOVÁ VACULOVÁ Alena TYLICHOVÁ Zuzana LAUKOVÁ Jarmila KOZUBÍK Alois

Konferenční abstrakty

Rok: 2013, druh: Konferenční abstrakty
Oxaliplatin with PPARg ligand modulate regulation of the cell cycle and cell death of colon tumors

STRAKOVÁ Nicol HOFMANOVÁ Jiřina SOUČEK Karel FEDR Radek HYRŠLOVÁ VACULOVÁ Alena ZAPLETAL Ondřej TYLICHOVÁ Zuzana LAUKOVÁ Jarmila BOUCHAL Jan EHRMANN Jiří KOLÁŘ Zdeněk KOZUBÍK Alois

Konferenční abstrakty

Rok: 2013, druh: Konferenční abstrakty
Rosiglitazone acts as an efficient modulator of LA-12-induced cytotoxic and cytostatic response of colon cancer cells.

LAUKOVÁ Jarmila JELÍNKOVÁ Iva HOFMANOVÁ Jiřina STRAKOVÁ Nicol SOVA Petr EHRMANN Jiří KOLÁŘ Zdeněk KOZUBÍK Alois HYRŠLOVÁ VACULOVÁ Alena

Konferenční abstrakty

Rok: 2013, druh: Konferenční abstrakty
Rosiglitazone efficiently sensitizes human colon cancer cells to LA-12-induced apoptosis

LAUKOVÁ Jarmila JELÍNKOVÁ Iva HOFMANOVÁ Jiřina SOVA Petr KOZUBÍK Alois HYRŠLOVÁ VACULOVÁ Alena

Konferenční abstrakty

Rok: 2013, druh: Konferenční abstrakty
Rosiglitazone-mediated stimulation of LA-12-induced apoptosis is accompanied by changes in colon cancer cell cycle progression.

LAUKOVÁ Jarmila HOFMANOVÁ Jiřina SOVA Petr STRAKOVÁ Nicol EHRMANN Jiří KOLÁŘ Zdeněk KOZUBÍK Alois HYRŠLOVÁ VACULOVÁ Alena

Konferenční abstrakty

Rok: 2013, druh: Konferenční abstrakty
The novel combination of rosiglitazone and platinum (IV) compound LA-12 exerts cooperative cytotoxic effects in colon cancer cells associated with activation of mitochondrial apoptotic pathway.

LAUKOVÁ Jarmila JELÍNKOVÁ Iva HOFMANOVÁ Jiřina SOVA Petr KOZUBÍK Alois HYRŠLOVÁ VACULOVÁ Alena

Konferenční abstrakty

Rok: 2013, druh: Konferenční abstrakty

2012

Rosiglitazone-mediated enhancement of LA-12-induced colon cancer cell apoptosis was associated with stimulation of mitochondrial pathway

LAUKOVÁ Jarmila JELÍNKOVÁ Iva STRAKOVÁ Nicol HOFMANOVÁ Jiřina SOVA Petr KOZUBÍK Alois HYRŠLOVÁ VACULOVÁ Alena

Konferenční abstrakty

Rok: 2012, druh: Konferenční abstrakty

Projekty

Výuka

Studijní programy

Jaké je to být prvákem na MUNI?

Přečtěte si o výzkumu na MU

Mgr. Jarmila Herůdková, Ph.D.

2013

Combined treatment of PPARgamma ligand with oxaliplatin affect the cell cycle and death in colon cell line both sensitive and resistant to oxaliplatin

Oxaliplatin with PPARg ligand modulate regulation of the cell cycle and cell death of colon tumors

Rosiglitazone acts as an efficient modulator of LA-12-induced cytotoxic and cytostatic response of colon cancer cells.

Rosiglitazone efficiently sensitizes human colon cancer cells to LA-12-induced apoptosis

Rosiglitazone-mediated stimulation of LA-12-induced apoptosis is accompanied by changes in colon cancer cell cycle progression.

The novel combination of rosiglitazone and platinum (IV) compound LA-12 exerts cooperative cytotoxic effects in colon cancer cells associated with activation of mitochondrial apoptotic pathway.

2012

Rosiglitazone-mediated enhancement of LA-12-induced colon cancer cell apoptosis was associated with stimulation of mitochondrial pathway